3rdEyeBio Overview
- Investor Type
-
Accelerator/Incubator
- Status
-
Active
- Professionals
-
1
- Investments
-
8
- Portfolio
-
7
- Exits
-
1
3rdEyeBio General Information
Company Description
Founded in 2017, 3rdEyeBio is an accelerator/incubator based in Seattle, Washington. The firm seeks to invest in the healthcare industry.
Business Details
Website
www.3rdeyebio.comYear Founded
Investor Status
Primary Investor Type
Corporate Office
- North-East 85th Street
- Suite A
- Seattle, WA 98115
- United States
3rdEyeBio Investments (8)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| SEngine Precision Medicine | 10-Mar-2023 | Later Stage VC | Drug Delivery | Generating Revenue | ||
| Novilla Pharmaceuticals | 01-Nov-2021 | Drug Discovery | Clinical Trials - Phase 1 | |||
| AmunBio | 01-Jul-2021 | Drug Discovery | Pre-Clinical Trials | |||
| Corea Therapeutics | Drug Discovery | Startup | ||||
| Ozette | Biotechnology | Generating Revenue | ||||
| Partura | Therapeutic Devices | Generating Revenue | ||||
| Sync.MD | Accelerator/Incubator | Medical Records Systems | Generating Revenue | |||
| XtremisBio | Accelerator/Incubator | Drug Discovery | Startup |
3rdEyeBio Exits (1)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| SEngine Precision Medicine | 03-Oct-2023 |
3rdEyeBio Investments by Industry, Year, and Region
3rdEyeBio FAQs
-
What is 3rdEyeBio?
Founded in 2017, 3rdEyeBio is an accelerator/incubator based in Seattle, Washington.
-
When was 3rdEyeBio founded?
3rdEyeBio was founded in 2017.
-
Where is 3rdEyeBio headquartered?
3rdEyeBio is headquartered in Seattle, WA.
-
How many investments has 3rdEyeBio made?
3rdEyeBio has made 8 investments.
-
What has 3rdEyeBio invested in?
3rdEyeBio has made numerous investments in companies like SEngine Precision Medicine, Novilla Pharmaceuticals, and AmunBio within the Drug Delivery and Drug Discovery industries.
-
What has 3rdEyeBio invested in recently?
3rdEyeBio's latest investment was on 10-Mar-2023 in SEngine Precision Medicine, a company within the Drug Delivery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process